FDA Inspection
Stokes Healthcare Inc. dba Epicur PharmaStokes Healthcare Inc. dba Epicur Pharma – FDA Inspection, Feb 12, 2016
Record Details
This FDA Inspection record concerns Stokes Healthcare Inc. dba Epicur Pharma, with an inspection on February 12, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 12, 2016
- Product Type
- Drugs
View Company Profile
ID · bf8ac20a-f9bd-4843-97e0-1fb793447dc6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 957841
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- 483 Response
FDA Citations
5- 21 CFR 211.42(c)(10)(iii)Air Supply
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.42(c)(10)Aseptic Processing Area
- 21 CFR 211.80(a)Written Procedures Not Followed
- 21 CFR 211.198(a)Reporting of adverse drug experience to FDA
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Stokes Healthcare Inc. dba Epicur Pharma
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 23, 2025 | OAI | New Jersey District Office | Drug Quality Assurance |
| October 25, 2023 | OAI | Drug Quality Assurance | |
| June 19, 2018 | Not classified | New Jersey District Office |
Other documents for Stokes Healthcare Inc. dba Epicur Pharma
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.